CA
NZ
UK
AU
IND
US
Nektar Therapeutics (NASDAQ:NKTR) came into the session with a courtroom victory to celebrate: a federal jury in the Northern District of California found that Eli Lilly had breached the implied covenant of good faith and fair dealing in its license agreement for rezpegaldesleukin, the …
● GT Biopharma regainedNasdaqbid price compliance after closing above $1.00 for ten consecutiveBusinessdays as of September 22, 2026.
Moleculin Biotech (NASDAQ:MBRX) Penny Stock, a Houston-area clinical-stage cancer drug developer, spiked during Friday's session before closing higher on theNasdaqComposite after announcing new preclinical data for its lead drug candidate, Annamycin, also known by the proposed name naxtarubicin. The data was presented at the …
● Shareholders of Dror Ortho-Design (OTC:DROR) approved a reverse split ratio ranging from 1-for-2 to 1-for-2,000 at a September 23, 2026 special meeting.
● Dyadic International received twoNasdaqdeficiency notices at once: a bid price below $1.00 and aMarket Valuebelow $35 million.
● BioLineRx filed an F-1 to register up to 2,023,382 ADSs issuable to ArmisticeCapitaluponWarrantexercise.
IEH Corporation (OTC:IEHC), a Brooklyn connector maker best known for its work on missile programs, said it had received $3.6 million in new orders for its hyperboloid connectors from what it called a leading maker of mobile defibrillators. Shares rose on the OTC market …
Jaguar Health (NASDAQ:JAGX) has had one of the most volatile weeks on the Nasdaq Composite, spiking after saying the FDA had granted it fee waivers, then swinging sharply lower before moving higher again at last closing on heavy volume. In the middle of that …
Glucotrack, Inc. (NASDAQ:GCTK)Penny Stockfell sharply after announcing it had priced a registered direct offering worth about $3.1 million in gross proceeds, a day after shares had jumped strongly on news about the company's Lōkahi Therapeutics business. The offering priced well below the prior close, …
Dror Ortho-Design, Inc. (OTC:DROR), a Jerusalem-based developer of teeth-straightening technology, reported that its stockholders approved a reverse stock split at a special meeting, granting the board authority to combine shares at any ratio between 1-for-2 and 1-for-2,000, with the exact ratio left to the …
Please wait processing your request...